# NorthEast Community Bancorp, Inc.: financial statements, quarterly

NECB · Nasdaq · CIK 1847398 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/necb.md) · [Financials](/companies/necb/financials.md) · [Filings](/companies/necb/filings.md) · [Insiders](/companies/necb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/necb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [10.0](/filings/0001558370-23-018773.md) | [11.9 d](/filings/0001558370-24-004281.md) | [13.1](/filings/0001558370-24-007529.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [4.4](/filings/0001558370-24-014834.md) | [5.1 d](/filings/0001558370-25-002975.md) | [4.7](/filings/0001558370-25-007099.md) | [4.9](/filings/0001558370-25-010872.md) | [4.9](/filings/0001104659-25-108218.md) | [4.3 d](/filings/0001104659-26-027566.md) | [4.1](/filings/0001104659-26-057657.md) | [4.3](/filings/0001104659-26-092404.md) | [4.7](/filings/0001104659-25-108218.md) | [4.8 d](/filings/0001104659-26-027566.md) | [4.1](/filings/0001104659-26-057657.md) | [4.0](/filings/0001104659-26-092404.md) |
| Net income | $m | [11.8](/filings/0001558370-24-014834.md) | [12.1 d](/filings/0001558370-25-002975.md) | [11.4](/filings/0001104659-25-108218.md) | [12.8](/filings/0001104659-25-108218.md) | [12.7](/filings/0001104659-25-108218.md) | [10.2 d](/filings/0001104659-26-027566.md) | [10.6](/filings/0001104659-26-092404.md) | [11.2](/filings/0001104659-26-092404.md) | [11.9](/filings/0001104659-25-108218.md) | [10.8 d](/filings/0001104659-26-027566.md) | [10.0](/filings/0001104659-26-092404.md) | [9.8](/filings/0001104659-26-092404.md) |
| Diluted EPS | $ per share | [0.80](/filings/0001558370-24-014834.md) | not reported | [0.86](/filings/0001558370-25-007099.md) | [0.97](/filings/0001558370-25-010872.md) | [0.95](/filings/0001104659-25-108218.md) | not reported | [0.78](/filings/0001104659-26-057657.md) | [0.82](/filings/0001104659-26-092404.md) | [0.87](/filings/0001104659-25-108218.md) | not reported | [0.74](/filings/0001104659-26-057657.md) | [0.72](/filings/0001104659-26-092404.md) |
| Basic EPS | $ per share | [0.80](/filings/0001558370-24-014834.md) | not reported | [0.87](/filings/0001558370-25-007099.md) | [0.98](/filings/0001558370-25-010872.md) | [0.97](/filings/0001104659-25-108218.md) | not reported | [0.80](/filings/0001104659-26-057657.md) | [0.85](/filings/0001104659-26-092404.md) | [0.90](/filings/0001104659-25-108218.md) | not reported | [0.76](/filings/0001104659-26-057657.md) | [0.75](/filings/0001104659-26-092404.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [107](/filings/0001558370-23-018773.md) | [68.7](/filings/0001558370-25-002975.md) | [107](/filings/0001558370-24-007529.md) | [114](/filings/0001558370-24-011687.md) | [97.8](/filings/0001558370-24-014834.md) | [78.3](/filings/0001104659-26-027566.md) | [89.5](/filings/0001558370-25-007099.md) | [59.4](/filings/0001558370-25-010872.md) | [64.3](/filings/0001104659-25-108218.md) | [81.2](/filings/0001104659-26-092404.md) | [76.2](/filings/0001104659-26-057657.md) | [73.4](/filings/0001104659-26-092404.md) |
| Total assets | $m | [1,720](/filings/0001558370-23-018773.md) | [1,764](/filings/0001558370-25-002975.md) | [1,867](/filings/0001558370-24-007529.md) | [1,930](/filings/0001558370-24-011687.md) | [1,968](/filings/0001558370-24-014834.md) | [2,010](/filings/0001104659-26-027566.md) | [1,933](/filings/0001558370-25-007099.md) | [1,974](/filings/0001558370-25-010872.md) | [2,056](/filings/0001104659-25-108218.md) | [2,064](/filings/0001104659-26-092404.md) | [2,025](/filings/0001104659-26-057657.md) | [2,115](/filings/0001104659-26-092404.md) |
| Total liabilities | $m | [1,448](/filings/0001558370-23-018773.md) | [1,485](/filings/0001558370-25-002975.md) | [1,578](/filings/0001558370-24-007529.md) | [1,630](/filings/0001558370-24-011687.md) | [1,658](/filings/0001558370-24-014834.md) | [1,691](/filings/0001104659-26-027566.md) | [1,606](/filings/0001558370-25-007099.md) | [1,637](/filings/0001558370-25-010872.md) | [1,712](/filings/0001104659-25-108218.md) | [1,712](/filings/0001104659-26-092404.md) | [1,669](/filings/0001104659-26-057657.md) | [1,753](/filings/0001104659-26-092404.md) |
| Long-term debt | $m | [64.0](/filings/0001558370-23-018773.md) | [64.0](/filings/0001558370-25-002975.md) | [47.0](/filings/0001558370-24-007529.md) | [47.0](/filings/0001558370-24-011687.md) | [7.0](/filings/0001558370-24-014834.md) | not reported | not reported | [135](/filings/0001558370-25-010872.md) | [170](/filings/0001104659-25-108218.md) | [70.0](/filings/0001104659-26-092404.md) | [20.0](/filings/0001104659-26-057657.md) | [190](/filings/0001104659-26-092404.md) |
| Shareholders' equity | $m | [272](/filings/0001558370-24-014834.md) | [279](/filings/0001104659-26-027566.md) | [289](/filings/0001104659-25-108218.md) | [300](/filings/0001104659-25-108218.md) | [310](/filings/0001104659-25-108218.md) | [318](/filings/0001104659-26-092404.md) | [327](/filings/0001104659-26-092404.md) | [337](/filings/0001104659-26-092404.md) | [344](/filings/0001104659-25-108218.md) | [352](/filings/0001104659-26-092404.md) | [356](/filings/0001104659-26-092404.md) | [363](/filings/0001104659-26-092404.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [12.9 d](/filings/0001558370-24-014834.md) | [12.0 d](/filings/0001558370-25-002975.md) | [12.9](/filings/0001558370-25-007099.md) | [11.1 d](/filings/0001558370-25-010872.md) | [14.4 d](/filings/0001104659-25-108218.md) | [10.2 d](/filings/0001104659-26-027566.md) | [10.9](/filings/0001104659-26-057657.md) | [15.6 d](/filings/0001104659-26-092404.md) | [14.1 d](/filings/0001104659-25-108218.md) | [12.0 d](/filings/0001104659-26-027566.md) | [10.4](/filings/0001104659-26-057657.md) | [12.8 d](/filings/0001104659-26-092404.md) |
| Capital expenditure | $m | [0.2 d](/filings/0001558370-24-014834.md) | [0.2 d](/filings/0001558370-25-002975.md) | [0.1](/filings/0001558370-25-007099.md) | [0.1 d](/filings/0001558370-25-010872.md) | [0.2 d](/filings/0001104659-25-108218.md) | [0.1 d](/filings/0001104659-26-027566.md) | [0.4](/filings/0001104659-26-057657.md) | [0.8 d](/filings/0001104659-26-092404.md) | [0.4 d](/filings/0001104659-25-108218.md) | [0.2 d](/filings/0001104659-26-027566.md) | [0.1](/filings/0001104659-26-057657.md) | [0.1 d](/filings/0001104659-26-092404.md) |
| Dividends paid | $m | [0.9 d](/filings/0001558370-24-014834.md) | [0.9 d](/filings/0001558370-25-002975.md) | [0.8](/filings/0001558370-25-007099.md) | [1.4 d](/filings/0001558370-25-010872.md) | [1.4 d](/filings/0001104659-25-108218.md) | [4.2 d](/filings/0001104659-26-027566.md) | [2.1](/filings/0001104659-26-057657.md) | [2.8 d](/filings/0001104659-26-092404.md) | [2.8 d](/filings/0001104659-25-108218.md) | [5.6 d](/filings/0001104659-26-027566.md) | [2.8](/filings/0001104659-26-057657.md) | [2.8 d](/filings/0001104659-26-092404.md) |
| Share repurchases | $m | [8.9 d](/filings/0001558370-24-014834.md) | [5.3 d](/filings/0001558370-25-002975.md) | [1.3](/filings/0001558370-25-007099.md) | [1.2 d](/filings/0001558370-25-010872.md) | [0.0 d](/filings/0001104659-25-108218.md) | [0.7 d](/filings/0001104659-26-027566.md) | not reported | not reported | not reported | [1.4 d](/filings/0001104659-26-027566.md) | [3.6](/filings/0001104659-26-057657.md) | [1.1 d](/filings/0001104659-26-092404.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [15.5](/filings/0001558370-23-018773.md) | [14.7](/filings/0001558370-24-007529.md) | [14.7](/filings/0001558370-24-011687.md) | [14.8](/filings/0001558370-24-014834.md) | [13.2](/filings/0001558370-25-007099.md) | [13.2](/filings/0001558370-25-010872.md) | [13.4](/filings/0001104659-25-108218.md) | [13.6](/filings/0001104659-26-057657.md) | [13.6](/filings/0001104659-26-092404.md) | [13.6](/filings/0001104659-25-108218.md) | [13.5](/filings/0001104659-26-057657.md) | [13.5](/filings/0001104659-26-092404.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 13,766,059 at 2026-08-05, from the cover of the [10-Q filed 2026-08-07](/filings/0001104659-26-092404.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.